Endoscopy 2020; 52(S 01): S221
DOI: 10.1055/s-0040-1704691
ESGE Days 2020 ePoster Podium presentations
Saturday, April 25, 2020 11:30 – 12:00 How to maximize detection and ePoster Podium 4reporting in colonoscopy?
© Georg Thieme Verlag KG Stuttgart · New York

IS THE ADENOMA DETECTION RATE AN IMPORTANT INDICATOR IN THE DETECTION OF OTHER NON-NEOPLASTIC FINDINGS?

aC Gomes
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
A Ponte
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
R Pinho
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
A Rodrigues
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
AP Silva
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
M Sousa
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
JC Silva
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
E Afecto
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
J Carvalho
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

 

Aims Adenoma detection rate (ADR) is the proportion of screening colonoscopy patients who are found to have at least one adenoma. ADR has been inversely associated with the risk of CRC and death. However little is known about the correlation of the adenoma detection rate and the detection of other non-neoplasic findings. The aim of this study was to evaluate if ADR is associated with a higher detection of non-neoplasic findings.

Methods We retrospectively analyzed patients undergoing colonoscopy by three endoscopists at our center (A, B, C). Angiodysplasia, diverticula, nonspecific inflammation, erosions or ulcers or subepithelial lesions were considered non-neoplastic findings.

Results A total of 229 colonoscopies were analyzed. The mean age was 64 ± 13.1 years-old. 54.6% were male (n = 125). The median ASA score was 2 (IQR: 1–3). The mean indication was post-polypectomy surveillance 25.8% (n = 59), followed by CRC surveillance 27.1% (n = 62) and screening for CRC 20.5% (n = 47). The indication for colonoscopy was significantly different between groups (p = 0.04): CRC surveillance was higher in endoscopist B (31.9%, n = 23) and C (36.5%, n = 23), and post-polypectomy surveillance was higher in endoscopist A (35.1%, n = 33). An excellent bowel cleansing was higher in colonoscopies performed by endoscopist A (A. 59.6% vs. B: 48.6% vs. C: 19%, p < 0.01). The global ADR was 36.2% (n = 83) and was not significantly different between endoscopists (A: 42.6% vs. B: 36.1% vs. C: 27%, p = 0.14). The ADR was not associated with higher detection rate of non-neoplasic findings (31.3% vs 30.1%, p = 0.88), even when concerning each endoscopist (A: 27.5% vs 33.3%, p = 0.65; B: 38.5% vs 23.9%, p = 0.28 e C: 29.4% vs 32.6%, p = 0.81).

Conclusions In our study, ADR was not associated with a better detection of other non-neoplastic findings in the total sample and by endoscopist.